John Leonard, MD, Intellia Therapeutics president and CEO Addressing analysts in August, Intellia Therapeutics (NASDAQ: NTLA) president and CEO John Leonard, MD, announced that, given greater-than-expected patient enrollment in a Phase III trial assessing nexiguran […]
Novartis said it is acquiring Avidity Biosciences for approximately $12 billion, the companies said Sunday, in a deal designed to bolster the buyer’s neuroscience pipeline with three late-stage programs. Headquartered in San Diego, Avidity is […]
Novartis has taken up its option to license antisense oligonucleotide TQJ230, triggering a $150 million payout that Akcea Therapeutics will share with Ionis Pharmaceuticals. The decision sets Novartis up to test the RNA-targeting drug in […]
DNA is spelled out with four letters, or bases. Researchers have now built a system with eight. It may hold clues to the potential for life elsewhere in the universe and could also expand our […]
Takeda predicts that climate change will help its Zika and dengue fever vaccines find a larger market. Roche says it could ultimately make it attractive for the company to develop treatments for diseases like malaria. […]
Late last month, Gossamer Bio filed to raise up to $230 million in a fixed-price IPO so it could go public despite the partial shutdown of the U.S. government. Now that the government has reopened, […]
CHICAGO (GenomeWeb) ? In December, LunaPBC, the public-benefit corporation that operates the LunaDNA genomic data platform, won approval from the US Securities and Exchange Commission to recognize personal health data, including genomes, as a form […]
financial windpipe for growing companies ? the ability to raise money through stock offerings ? is increasingly constricted by the partial government shutdown, industry experts say. Source: Public stock offerings hit by partial government shutdown […]
San Diego-based Technology startup BlueNalu recently announced its new, nine-member advisory board, which includes Pierre-Yves Cousteau?a global environmental consultant and president of Cousteau Divers, an organization dedicated to continue the goals of his late father, […]
From day 1 Gos?samer has al?ways been a biotech in a hurry. And they?re not about to let a lit?tle thing like a gov?ern?ment shut?down stymy their plans for an IPO. Source: Shutdown thrusts Gossamer […]
While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some. Source: Attendees fed up with venue, […]
Roswell Biotechnologies, a life-science upstart in San Diego, has secured $32 million from investors to develop an unusual new way to sequence DNA for cheap ? a feat they hope will dramatically bring down the […]
UC San Diego researchers say they?ve discovered a major reason why skin ages, and how skin aging impairs resistance to infections. And they?ve found a way to fix it, at least in mice. In aging, skin cells called fibroblasts lose their ability to ma… […]
Gossamer Bio, headed by former Receptos executives, made its public debut in January with $100 million in financing. Seven months later, it tacked on another $230 million. Now, the San Diego-based startup is looking to Wall Street for additional funds…. […]
Some people appear to be considerably younger or older than their chronological age. Genetic signatures that may help explain this have been discovered by scientists at the Salk Institute. The age-associated genetic patterns were found by analyzing… […]
Twelve patients contracted serious infections after being given products supposedly containing stem cells from a San Diego company, the U.S. Food and Drug Administration said Thursday. The company, Genetech, is unrelated to Genentech, the large bio… […]
San Diego?s life sciences companies didn?t tap their brakes much as December chugged along. This week?for many, the last full work week before a holiday break?has been peppered with financings and deals news. So while it might be nearly time to board y… […]
Reports + Research San Diego?s Best IPO Year Since 2014 This year was San Diego?s best year for companies seeking to ?go public? with an initial public offering (IPO). Xconomy reports that seven local companies, six in life sciences and one in tech, co… […]
Hav?ing es?tab?lished Ionis $IONS as a well?spring of Big Pharma in?no?va?tion, founder and chief?Stan?ley Crooke is tran?si?tion?ing to ex?ec?u?tive chair?man of the an?ti?sense com?pany?s board come 2020, when cur?rent COO?Brett Monia will take over the […]
A court in Munich, Germany, has ordered Apple to stop imports and sales in Germany of all models of iPhone that infringe on Qualcomm?s intellectual property, the San Diego wireless giant said Thursday. The court ruled that Cupertino, CA-based Apple (NA… […]
New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that?s ready for Phase 2 study. The San Diego, CA, company made its pu… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/fasterscience?src=hash" target="_blank"gt;#fastersciencelt;/agt;–Scientist.com, the world’s leading marketplace for outsourced scientific research, was recognized a… […]
A lawsuit by Human Longevity against the J. Craig Venter Institute alleging theft of trade secrets has been dismissed. The dismissal order was filed Wednesday in U.S. District Court for the Southern District of California by Judge William Q. Hayes…. […]
A California judge has dismissed a suit in which genomics pioneer Craig Venter?s old company accused him of stealing trade secrets, ending a protracted and messy breakup. […]
RiverVest Venture Partners, a St. Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVes… […]
John McKearn
RiverVest Venture Partners first closed its fourth fund late last year with a continued mission to bankroll drug and medical device projects that target unmet medical needs. Eight investments ? including three new companies ? later, the St… […]
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc., a privately held, clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, tod… […]
SAN DIEGO–(BUSINESS WIRE)–ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, has raised $20 milli… […]
Copyright © 2026 Biotech Networks, LLC
